China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report report published on Saturday morning. The firm issued a hold rating on the stock.

China Pharma Price Performance

Shares of CPHI opened at $0.32 on Friday. The company has a 50-day moving average of $0.38 and a two-hundred day moving average of $0.48. The company has a current ratio of 0.88, a quick ratio of 0.33 and a debt-to-equity ratio of 0.19. China Pharma has a one year low of $0.30 and a one year high of $2.70.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.